Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria Group Inc. MO, -0.37% said Thursday it will conduct an independently-led equity and civil rights assessment in the next 12 months after a 2022 shareholder resolution passed. The assessment will review Altria's policies and practices to address “the harm associated with tobacco use and the effectiveness of our harm reduction efforts.

Altria sets up independent equity and civil rights assessment after shareholder resolution

RICHMOND, Va.--( BUSINESS WIRE )--Altria Group, Inc. (NYSE: MO) today announces that we will conduct an equity and civil rights assessment (Assessment). The Assessment follows last year's passage of a shareholder proposal recommending Altria commission a civil rights equity audit and seeks to address feedback received from recent robust shareholder engagement. We believe the Assessment will identify opportunities to accelerate progress toward our 2025 Corporate Responsibility focus area goals, enhance stakeholder alignment and promote transparency.

Altria to Conduct an Equity and Civil Rights Assessment

Hershey

These two companies provide a great balance between immediate income and dividend growth prospects.

2 Monster Stocks With Major Passive Income Potential

Bull flagging on the charts, tobacco stock Altria Group Inc (NYSE:MO) has found support at its 20-week moving average, which coincides with both its Covid low and its anchored VWAP (AVWAP).

Tobacco Stock for Options Bulls to Light Up

Automatic Data Processing

Applied Materials

Broadcom

Franklin Resources

BHP Billiton

Blackstone Group

Boston Properties

Cigna

Comcast

Costco

Coterra Energy

Chevron

Digital Realty Trust

EOG Resources

Enterprise Products Partners

Invitation Homes

Johnson & Johnson

Lennar

Lowe's

LyondellBasell Industries

Merck

Microsoft

Newmont Mining

NIKE

This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe, dividend-paying, and are offering large discounts to their historical norms. It's always a good idea to keep your wish list ready by separating the wheat from the chaff.

5 Relatively Safe And Cheap Dividend Stocks To Invest In - January 2023

Market sentiment sometimes creates absurd situations. And history has shown that absurdity often creates unusual opportunities.

The Altria Absurdity: Yield Approaching P/E

H.B. Fuller

W.W. Grainger

Leggett & Platt

MSA Safety

Nordson

Stanley Black & Decker

Sysco

Tennant

V.F.

The 48 Dividend Kings ended the year with a loss in December, collectively down 3.95%. Last month, the 11 best dividend kings based on forecasted growth and valuation underperformed the average dividend king return by 140 bps.

My 11 Best Dividend Kings For January 2023

Apple

adidas AG

Alphabet

Coca-Cola

Lockheed Martin

Mastercard

Realty Income Corp

Philip Morris

Starbucks

AT&T

Unilever

iShares MSCI World ETF

Visa

Vanguard S&P 500 ETF

Verizon

ETFs offer a wide range of advantages over selecting stocks individually. These advantages include a broader risk diversification than when investing in individual stocks.

10 Dividend Stocks To Show The Advantages Of Investing In Individual Stocks Over ETFs

JPMorgan Chase & Co

Pfizer

Rio Tinto plc Sponsored

Vale S.A.

There are undervalued dividend stocks that look attractive for exposure for a variety of reasons. The International Monetary Fund head has warned that a third of the world will hit a recession in 2023.

7 Seriously Undervalued Dividend Stocks to Buy for High Total Returns

Altria stock (NYSE: MO) saw a 5% fall last year, faring better than the broader S&P500 index, which was down 20%.

What's Driving Growth For Altria Stock?

Phillip Morris and Altria should continue to do well during a harsh environment in 2023 on an operational basis. Currency rate movements could be an issue for PM, however.

Altria Vs. Philip Morris: One's Way Better

While the market had a nice bounce the last couple of months, there is still no shortage of stocks that are becoming fairly valued to undervalued. The silver lining amid the market collapse is that every new dollar put to work today in dividend stocks comes with an automatic higher yield when compared to just a few months ago.

January 2023 Stock Considerations

Enbridge

Essex Property Trust

First of Long Island

Fresenius Medical Care

Federal Realty Investment Trust

Dividend growth blue-chips are the best performing assets in history. There are no more dependable dividend growth blue-chips for the 2023 recession than dividends aristocrats.

The 9 Best 4+% Yielding Dividend Aristocrats For 2023

ABM Industries

Black Hills

Kimberly-Clark

National Fuel Gas

Northwest Natural Gas

Parker-Hannifin

Target

Universal Corp

"There is only one-criterion to be included among the Dividend Kings: a publicly-traded company must increase its total fiscal-year dividend-payout for a minimum of 50 consecutive-years." - Dogs of the Dow. The 41 Dividend Kings and 2 Princes (next in line for kingship) (K&P) screened as of December 28, 2022, represented ten of eleven Morningstar Sectors. Broker targeted-top-ten net-gainers ranged 9.61%-20.75%.

January Dividend Kings And Princes: 3 Buys And 2 To Watch

Bristol-Myers

In this article, I review the stocks of ten world-class companies that I either have in my portfolio or am in the process of building a position in. I point out the specifics of the companies' business models, discuss their profitability and balance sheet quality, and evaluate their dividend growth record and future prospects.

Your New Year's Resolution For 2023: Invest $10,000 In These 10 Stocks

News for Altria Stock (MO)